- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de University Hospital Heidelberg](/img/noimage_org.png)
University Hospital Heidelberg
Heidelberg, AlemaniaPublicacions en col·laboració amb investigadors/es de University Hospital Heidelberg (6)
2022
-
Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers
Epigenetics, Vol. 17, Núm. 2, pp. 117-132
-
Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)
International Journal of Molecular Sciences, Vol. 23, Núm. 18
2021
-
SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group
Stroke, Vol. 52, Núm. 5, pp. E117-E130
2017
-
The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study
Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752
2013
-
Brush border myosin Ia inactivation in gastric but not endometrial tumors
International Journal of Cancer, Vol. 132, Núm. 8, pp. 1790-1799
2012
-
Brush border Myosin Ia has tumor suppressor activity in the intestine
Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 5, pp. 1530-1535